Search Results - "Weaver, T. E."

Refine Results
  1. 1

    Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis by Hughes, K., Glass, C., Ripchinski, M., Gurevich, F., Weaver, T. E., Lehman, E., Fisher, L. H., Craig, T. J.

    Published in Allergy (Copenhagen) (01-05-2003)
    “…Background:  Improving quality of life is considered to be a major endpoint and motivation for clinical intervention in patients with perennial allergic…”
    Get full text
    Journal Article
  2. 2

    An instrument to measure functional status outcomes for disorders of excessive sleepiness by WEAVER, T. E, LAIZNER, A. M, DINGES, D. F, EVANS, L. K, MAISLIN, G, CHUGH, D. K, LYON, K, SMITH, P. L, SCHWARTZ, A. R, REDLINE, S, PACK, A. I

    Published in Sleep (New York, N.Y.) (01-10-1997)
    “…This article reports the development of the functional outcomes of sleep questionnaire (FOSQ). This is the first self-report measure designed to assess the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Human surfactant protein B: structure, function, regulation, and genetic disease by Whitsett, J A, Nogee, L M, Weaver, T E, Horowitz, A D

    Published in Physiological reviews (01-10-1995)
    “…Elucidation of the structure and function of the hydrophobic surfactant protein (SP-B) and the SP-B gene has provided critical insight into surfactant…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice by Clark, J C, Wert, S E, Bachurski, C J, Stahlman, M T, Stripp, B R, Weaver, T E, Whitsett, J A

    “…Surfactant protein B (SP-B) is an 8.7-kDa, hydrophobic protein that enhances the spreading and stability of surfactant phospholipids in the alveolus. To…”
    Get full text
    Journal Article
  7. 7

    Outcome measurement in sleep medicine practice and research. Part 2: assessment of neurobehavioral performance and mood by Weaver, T.E.

    Published in Sleep Medicine Reviews (01-06-2001)
    “…Neurobehavioral performance and alterations in mood consequent to sleep disorders and their treatment has recently been the focus of clinical investigations…”
    Get full text
    Book Review Journal Article
  8. 8

    Bacterial Killing Is Enhanced by Expression of Lysozyme in the Lungs of Transgenic Mice by Akinbi, Henry T, Epaud, Ralph, Bhatt, Hetal, Weaver, Timothy E

    Published in The Journal of immunology (1950) (15-11-2000)
    “…To assess the role of lysozyme in pulmonary host defense in vivo, transgenic mice expressing rat lysozyme cDNA in distal respiratory epithelial cells were…”
    Get full text
    Journal Article
  9. 9

    Night-to-night variability in CPAP use over the first three months of treatment by WEAVER, T. E, KRIBBS, N. B, DINGES, D. F, PACK, A. I, KLINE, L. R, CHUGH, D. K, MAISLIN, G, SMITH, P. L, SCHWARTZ, A. R, SCHUBERT, N. M, GILLEN, K. A

    Published in Sleep (New York, N.Y.) (01-04-1997)
    “…The purpose of this study was to examine the relationship between night-to-night variability and nightly duration of continuous positive airway pressure (CPAP)…”
    Get full text
    Journal Article
  10. 10

    Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid beta-peptide by Johansson, J, Weaver, T E, Tjernberg, L O

    “…The formation of amyloid fibrils is associated with several devastating diseases in humans and animals, including e.g. Alzheimer's disease (AD) and the…”
    Get full text
    Journal Article
  11. 11

    Bacterial killing is enhanced by exogenous administration of lysozyme in the lungs by Epaud, R., Delestrain, C., Weaver, T.E., Akinbi, H.T.

    Published in Respiratory medicine and research (01-11-2019)
    “…Lysozyme, a 14-kDa protein, is one of the most abundant antimicrobials in the lungs. Its concentration in airway surface sufficient to kill several bacterial…”
    Get full text
    Journal Article
  12. 12

    Lamellar Body Formation in Normal and Surfactant Protein B-Deficient Fetal Mice by Stahlman, Mildred T, Gray, Mary Phillips, Falconieri, Mary W, Whitsett, Jeffrey A, Weaver, Timothy E

    Published in Laboratory investigation (01-03-2000)
    “…Surfactant protein B (SP-B) −/− mice die of lethal respiratory distress syndrome shortly after birth. Alveolar type II epithelial cells in SP-B–deficient mice…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Intracellular processing of pulmonary surfactant protein B in an endosomal/lysosomal compartment by Voorhout, W F, Veenendaal, T, Haagsman, H P, Weaver, T E, Whitsett, J A, van Golde, L M, Geuze, H J

    Published in The American journal of physiology (01-10-1992)
    “…The hydrophobic surfactant protein B (SP-B) is synthesized in alveolar type II cells as a 40-kDa precursor protein that is processed via 39- and 23-kDa…”
    Get full text
    Journal Article
  14. 14

    Neurobehavioral consequences of arousals by CHUGH, D. K, WEAVER, T. E, DINGES, D. F

    Published in Sleep (New York, N.Y.) (01-12-1996)
    “…The neurobehavioral deficits of obstructive sleep apnea syndrome (OSAS) are often attributed to the rate of respiratory disturbance or rate of arousals during…”
    Get full text
    Conference Proceeding Journal Article
  15. 15

    Posttranslational processing of surfactant protein C in rat type II cells by Vorbroker, D K, Voorhout, W F, Weaver, T E, Whitsett, J A

    Published in The American journal of physiology (01-12-1995)
    “…Pulmonary surfactant consists of phospholipids and proteins that form a stable monolayer at the surface of the alveoli to prevent lung collapse. Surfactant…”
    Get full text
    Journal Article
  16. 16

    Processing of surfactant protein B proprotein by a cathepsin D-like protease by Weaver, T E, Lin, S, Bogucki, B, Dey, C

    Published in The American journal of physiology (01-07-1992)
    “…Surfactant protein B (SP-B) is a hydrophobic peptide of relative molecular weight (M(r)) = 8,000 that is associated with pulmonary surfactant phospholipids…”
    Get full text
    Journal Article
  17. 17

    Differential effects of epidermal growth factor and transforming growth factor-beta on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung by Whitsett, J A, Weaver, T E, Lieberman, M A, Clark, J C, Daugherty, C

    Published in The Journal of biological chemistry (05-06-1987)
    “…Differentiation of pulmonary Type II epithelial cells in late gestation is associated with the synthesis of pulmonary surfactant required for adaptation to air…”
    Get full text
    Journal Article
  18. 18

    Adherence to continuous positive airway pressure therapy: the challenge to effective treatment by Weaver, Terri E, Grunstein, Ronald R

    “…Despite the high efficacy of continuous positive airway pressure (CPAP) to reverse upper airway obstruction in sleep apnea, treatment effectiveness is limited…”
    Get full text
    Journal Article
  19. 19
  20. 20

    cDNA, deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid, SPL(pVal) by Glasser, S W, Korfhagen, T R, Weaver, T E, Clark, J C, Pilot-Matias, T, Meuth, J, Fox, J L, Whitsett, J A

    Published in The Journal of biological chemistry (05-01-1988)
    “…In hyaline membrane disease of premature infants, lack of surfactant leads to pulmonary atelectasis and respiratory distress. Hydrophobic surfactant proteins…”
    Get full text
    Journal Article